Furthermore, hypoglycemic agents such as pioglitazone and empagliflozin exhibit beneficial effects on liver tissue outcomes, such as reducing liver fat content and improving liver fibrosis (Jee et al., 2025
L., Sandalova, E., Guan, L., Feng, L., & Maier, A
The interpretation of these transcriptomic findings has been a continuing area of discussion, with some researchers viewing the broad effects as evidence of a regulatory function and others viewing them with caution given the difficulty of distinguishing direct effects from secondary consequences in such broad gene-expression landscapes
From boosting energy levels to improving heart health and mental clarity, the benefits are far-reaching